동국제약(주)

Dongkook Pharmaceutical Co., Ltd. is a leading global total healthcare company committed to enhancing well-being through innovative pharmaceutical solutions. Established in 1968, Dongkook Pharmaceutical has steadily grown into a prominent pharmaceutical manufacturer, driven by continuous product research and dedicated workforce development. The company’s commitment to quality and innovation is reflected in its advanced manufacturing facilities and research investments.

Located at Teheran-ro 108-gil 7, Gangnam-gu, Seoul, 06175, KR, Dongkook Pharmaceutical is known for its flagship products, including Insadol, Korea's first gum disease treatment, as well as advanced wound care solutions like Madecassol and stomatitis treatments such as Oramed. Dongkook Pharmaceutical consistently invests over 5% of its annual revenue in research and development, ensuring a pipeline of cutting-edge healthcare products.

Dongkook Pharmaceutical's reputation extends internationally, with its intravenous anesthetic agent, Propofol, receiving high praise in global markets. With a steadfast dedication to healthcare excellence, Dongkook Pharmaceutical Co., Ltd. continues to expand its product portfolio and global reach, solidifying its position as a trusted provider of healthcare solutions. We invite the management team at Dongkook Pharmaceutical to create a customized and exclusive company showcase and product listing on our platform to further amplify their market presence.